Extremity Dosimetry in Nuclear Medicine

Introduction

In nuclear medicine, the limiting organ for occupational radiation protection is usually not the whole body — it is the hands. Staff who draw, dispense, and inject unsealed radiopharmaceuticals hold vials and syringes centimeters from unshielded activity, and because dose rate falls with the square of distance, the fingertips can receive doses many times higher than a torso-worn badge records. Extremity dosimetry is the program that measures, tracks, and controls that dose so it stays below regulatory limits and as low as reasonably achievable (ALARA).¹³

The stakes are concrete. The annual limit on the shallow-dose equivalent to any extremity is 500 mSv, ten times the 50 mSv whole-body limit, precisely because the skin and extremities tolerate more dose than radiosensitive deep organs.¹⁸ Yet European measurement campaigns have shown that a meaningful fraction of nuclear medicine workers can approach that extremity limit, that the dose distribution across the hand is highly non-uniform, and — critically — that the standard ring dosimeter worn at the base of a finger systematically underestimates the true peak dose at the fingertips.³⁴ A monitoring program that ignores those findings can report "compliant" numbers while the actual skin dose runs higher.

This guide explains the extremity dose limit and the operational quantity behind it, when monitoring is required, how and where to wear a ring dosimeter, why placement matters so much, what doses the literature actually reports, and the practical controls that keep hands ALARA. It complements our companion pieces on occupational exposure monitoring and occupational eye lens dose, which together cover the three body regions — whole body, eye lens, and extremities — that a complete personnel-monitoring program must address. DRPS supports these programs through radiation safety officer and medical physics consulting services across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

Topic Explanation

The extremity dose limit and what it protects

The extremity limit is a skin limit. Under 10 CFR 20.1201, the occupational limit on the shallow-dose equivalent to the skin of the whole body or to the skin of any extremity is 50 rem — 0.5 Sv, or 500 mSv — in a year.¹ "Extremity" is defined to include the hands and forearms below the elbow and the feet and legs below the knee. The limit is set to prevent deterministic skin injury and to keep stochastic risk low, and it is higher than the 50 mSv whole-body total-effective-dose-equivalent limit because the skin and extremities are far less radiosensitive than the deep, blood-forming, and reproductive organs.¹⁸

The quantity actually measured is Hp(0.07), the personal dose equivalent at a depth of 0.07 mm — the depth of the radiosensitive basal layer of the epidermis. Extremity and skin dosimeters are calibrated in Hp(0.07), and it is this value that demonstrates compliance with the shallow-dose-equivalent limit.⁸

Why the hands, and why positron emitters especially

Three physical facts combine to make the hands the critical site:

• Proximity. During drawing and injection, the fingers are within a few centimeters of an unshielded source. The inverse-square law means that halving the distance quadruples the dose rate, so small changes in hand position produce large changes in dose.³
• Unsealed sources. Unlike a shielded X-ray tube, a radiopharmaceutical is a bare source that must be manipulated by hand, so shielding is never complete.
• Photon energy. Technetium-99m emits 140 keV photons; fluorine-18 annihilation produces 511 keV photons and gallium-68 similarly high-energy photons. The higher-energy positron emitters are harder to shield and deliver more dose per unit activity to the hands, which is why PET and theranostic workflows have intensified extremity-dose concerns.⁵⁶⁷

For the underlying emission characteristics that drive these differences, see our overview of common PET and radiopharmaceutical-therapy isotopes.

The non-uniformity problem

The single most important lesson from extremity-dose research is that the dose across the hand is not uniform, and the maximum is usually at the fingertips. The European ORAMED campaign, which measured dose distributions across the hands of nuclear medicine staff, found large variations across the hand depending on the task and radiopharmaceutical and emphasized that the position of the extremity dosimeter is fundamental to obtaining a correct estimate of the maximum skin dose.³ A focused study of FDG dispensing quantified the gap directly: the dose at the distal phalanx (fingertip) was on average about 1.7 times the dose at the proximal phalanx (finger base) where rings are typically worn.⁴ A ring at the base can therefore read comfortably below the limit while the fingertips receive substantially more.

Key Technical Principles

Estimating and projecting extremity dose

The instantaneous hand dose is governed by the cardinal principles of time, distance, and shielding. For a point source of activity $A$ with an extremity dose-rate coefficient ${\Gamma }_{\text{ext}}$ (Hp(0.07) per unit activity at a reference distance), the dose rate at distance $d$ follows the inverse-square law:

and the dose accumulated during a manipulation of duration $t$ is $H={\dot{H}}_{0.07}t$. The practical management question, however, is the annual projection: does the per-procedure dose, multiplied by the workload, approach the 500 mSv limit?

Worked example. Suppose a technologist receives a finger dose of $H_{\text{procedure}}=0.30\text{mSv}$ per gallium-68 PET preparation-and-injection — consistent with measured per-procedure finger doses for Ga-68 agents⁷ — and performs $n=8$ such procedures per day for $d=230$ working days per year:

This exceeds the 500 mSv extremity limit. Now apply a realistic dose-reduction factor from a tungsten syringe shield and good technique — say a factor of 4:

The shielded projection is well within the limit but still large enough that the worker must be monitored and the RSO should track trends. The example makes two points at once: unshielded high-throughput PET work can genuinely approach the extremity limit, and engineering controls change the answer by an order of magnitude.

Correcting for fingertip underestimation

Because the ring reads at the finger base but the maximum is at the fingertip, the measured value must be interpreted, not taken at face value. A correction factor $k$ relates the measured base dose to the estimated peak:

Measured fingertip-to-base ratios around 1.7 for FDG dispensing give a practical starting point for $k$, though the true factor depends on the radiopharmaceutical, the manipulation, and hand geometry, and is best established by a workplace study for each specific task.³⁴ If a ring reads 300 mSv over a year at the base, a $k$ of about 1.7 implies a fingertip dose near 500 mSv — the difference between "half the limit" and "at the limit." This is why placement and interpretation, not just the raw badge reading, define a defensible extremity program.

What the literature reports

Measured hand and finger doses span a wide range depending on radiopharmaceutical, activity handled, and — decisively — shielding and technique. The table below summarizes representative peer-reviewed measurements.

Two patterns stand out. First, per-procedure doses of a few tenths of a millisievert, multiplied by realistic annual workloads, are exactly the range that can approach the 500 mSv limit — the worked example above is not a contrived edge case. Second, shielding and technique repeatedly cut the dose by large factors; the same studies that report high unshielded values also document the reductions achieved with syringe shields, semi-automated injectors, and efficient workflow.⁵⁶

Clinical Impact

A well-run extremity-dose program does three things: it keeps workers below the limit, it prevents the "compliant on paper, high in reality" trap, and it feeds continuous improvement. The clinical and operational consequences of getting it right — or wrong — are significant.

When extremity monitoring is treated as a checkbox, a ring at the finger base can report reassuring numbers while fingertip dose runs meaningfully higher, and a genuine overexposure can go unrecognized until a dosimeter is read weeks later. When it is treated as a program, the ring reading is interpreted with a task-specific correction factor, trends are reviewed at the Radiation Safety Committee, and rising doses trigger a workflow review before anyone approaches a limit.

The differences that matter clinically are almost always about technique and engineering controls, not exotic equipment. The literature is consistent that syringe shields, vial shields, distance tools, and automated dispensing dramatically reduce hand dose — often by factors of several.⁵⁶ Because these controls also speed up and standardize workflow, an investment in extremity-dose reduction frequently pays back in both safety and efficiency. For facilities expanding into higher-energy PET and theranostic agents, revisiting extremity controls is not optional: the same manual technique that was adequate for technetium-99m can push fingertip dose much higher with fluorine-18 or gallium-68.⁶⁷

Finally, extremity dose intersects with contamination control and waste handling. Handling contaminated syringes, needles, and absorbent materials adds to hand dose and to skin-contamination risk, so extremity protection and contamination protocols reinforce each other — see nuclear medicine decontamination best practices and radioactive waste management.

Practical Optimization Tips

Monitor correctly

• Issue rings to everyone who meets the trigger. Under 10 CFR 20.1502, monitor the extremities of any adult likely to exceed 10% of the limit — more than 50 mSv to the extremities in a year.² Most staff routinely handling unsealed PET or gamma-emitting activity qualify.
• Place the ring on the most-exposed hand, on the palmar surface at the base of the index finger, sensitive element toward the source.³⁴
• Apply a task-specific correction factor to estimate the fingertip maximum rather than reporting the base reading as the peak.³⁴
• Use appropriate detectors. Thin lithium-fluoride thermoluminescent elements respond well across the relevant energies used in nuclear medicine.³

Control the dose at the source

• Shield the syringe and the vial. Tungsten syringe shields and vial shields are the highest-yield single controls.⁵⁶
• Keep unshielded activity behind an L-block or in a shielded dispensing station, and never let a bare source sit on the bench.
• Maximize distance. Use tongs, forceps, and long-handled tools; a small increase in distance is amplified by the inverse-square law.
• Work efficiently and rehearse. Practicing the manipulation without activity ("cold runs") shortens the live handling time.
• Automate where possible. Semi-automated dispensers and injectors can reduce hand dose by large factors and standardize the workflow.⁵
• Prefer unit doses when practical. Receiving patient-ready unit doses eliminates on-site multidose drawing, one of the higher-dose tasks.⁵

Manage the program

• Trend and review. Review extremity results at the Radiation Safety Committee and act on rising trends before they approach investigational levels.
• Set investigational levels. Local action thresholds well below the limit give early warning and drive ALARA.
• Train to technique. Most hand dose is technique-driven; competency training on shielding, distance, and speed is the most cost-effective intervention — see our radiation safety training support.

Common pitfalls to avoid

• Reading the ring literally. Ignoring fingertip underestimation understates the true peak skin dose.³⁴
• Wearing the ring on the wrong hand or orientation. A ring on the less-exposed hand or with the element facing away misses the dose it exists to catch.
• Assuming Tc-99m technique transfers to F-18/Ga-68. Higher photon energy demands better shielding and distance discipline.⁶⁷
• Skipping monitoring for "occasional" handlers. The 10% trigger is an annual projection; even part-time handlers of high-energy activity can cross it.
• Treating extremity dose as separate from contamination control. Handling contaminated sharps raises both hand dose and skin-contamination risk.

Regulatory Considerations

Extremity dosimetry in nuclear medicine sits under NRC (or Agreement State) radioactive-material regulation, and the governing numbers are specific and enforceable. The two central rules are the dose limit and the monitoring trigger.

• 10 CFR 20.1201 — Occupational dose limits for adults. Sets the shallow-dose-equivalent limit to the skin of any extremity at 50 rem (500 mSv) per year, distinct from the 5 rem (50 mSv) total-effective-dose-equivalent limit.¹
• 10 CFR 20.1502 — Conditions requiring individual monitoring. Requires monitoring of extremity dose for adults likely to receive, in one year, more than 10% of the applicable limit — i.e., more than 5 rem (50 mSv) to the extremities.²

These are administered by the NRC directly in non-Agreement jurisdictions and by Agreement States under compatible rules. Of the jurisdictions DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that regulate medical use of radioactive material under their own compatible programs, while Washington, DC and Delaware are regulated directly by the NRC. A facility must confirm which authority issues its license and apply that authority's monitoring, record-keeping, and reporting requirements. The international framework is consistent: ICRP Publication 103 sets the 500 mSv extremity limit in its system of dose limits, and the IAEA International Basic Safety Standards (GSR Part 3) require individual monitoring of extremities where doses may be significant.⁸⁹

Records of extremity dose must be maintained, results must be communicated to workers, and the program should be documented so it is defensible during inspection. For the broader personnel-monitoring picture, see occupational exposure monitoring and the NRC occupational dose limits under Part 20. Extremity monitoring should be coordinated with the RSO program, license conditions, and staff training. DRPS supports this through radiation safety officer and radioactive material license support services.

Frequently Asked Questions (FAQs)

What is the annual dose limit for the extremities in nuclear medicine?

Under 10 CFR 20.1201, the occupational limit on the shallow-dose equivalent to the skin of any extremity — the hands, forearms, feet, and ankles — is 50 rem (0.5 Sv, or 500 mSv) per year. This is separate from and much higher than the 5 rem (50 mSv) annual limit on total effective dose equivalent, because the extremities are less radiosensitive than the whole body.

Why do nuclear medicine workers receive high doses to their hands?

Because the hands are closest to unshielded activity during drawing, dispensing, and injecting radiopharmaceuticals. Dose rate falls with the square of distance, so fingertips a few centimeters from a vial or syringe receive far more than the whole body. Higher-energy positron emitters such as fluorine-18 (511 keV) and gallium-68 produce higher hand doses than technetium-99m.

Where should an extremity ring dosimeter be worn?

The ring is normally worn on the palmar (inside) surface of the base of the index finger of the most-exposed hand, with the sensitive element facing the source. Studies show the maximum dose is usually at the fingertips, so a ring worn at the finger base underestimates the true peak skin dose and a correction factor is often applied to estimate the maximum.

When is extremity monitoring required?

Under 10 CFR 20.1502, an employer must monitor the occupational dose to the extremities of any adult likely to receive, in one year, a dose in excess of 10 percent of the applicable limit — that is, more than 5 rem (50 mSv) to the extremities. In practice, most staff who routinely handle unsealed positron- or gamma-emitting radiopharmaceuticals meet this trigger and are issued ring dosimeters.

How much dose do the fingers actually receive per procedure?

Published measurements vary with radiopharmaceutical, activity, and shielding. For fluorine-18 FDG, per-procedure hand doses on the order of tens to a couple hundred microsieverts have been reported, and finger doses of roughly 0.3 millisieverts per procedure have been measured for gallium-68 PET agents. Summed over a busy year, these can approach or exceed the extremity limit without good technique.

What operational quantity does an extremity dosimeter measure?

Extremity and skin dosimeters report Hp(0.07), the personal dose equivalent at a tissue depth of 0.07 millimeters, which corresponds to the sensitive basal layer of the skin. This is the quantity used to demonstrate compliance with the shallow-dose-equivalent extremity limit.

What are the most effective ways to reduce hand dose?

Use syringe and vial shields, keep unshielded activity behind an L-block or in a shielded dispensing station, maximize distance with tongs or forceps, work quickly and practice unloaded runs, use automated or semi-automated dispensers and injectors where available, and prefer unit doses over on-site multidose drawing when practical. Time, distance, and shielding remain the cardinal controls.

Key Takeaways

• The extremities are the limiting organ. The 500 mSv annual extremity limit is ten times the whole-body limit, but hand doses in busy PET and theranostic work can approach it.¹
• Monitor by the rule. 10 CFR 20.1502 requires extremity monitoring for anyone likely to exceed 50 mSv to the extremities in a year — most unsealed-source handlers.²
• Placement is destiny. The maximum dose is at the fingertips; a ring at the finger base underestimates it, so apply a task-specific correction factor.³⁴
• Hp(0.07) is the quantity. Extremity dosimeters measure personal dose equivalent at 0.07 mm, matching the shallow-dose-equivalent limit.⁸
• Engineering controls dominate. Syringe and vial shields, distance, automation, and unit doses cut hand dose by large factors.⁵⁶
• Higher-energy emitters need better technique. Fluorine-18 and gallium-68 deliver more hand dose than technetium-99m; do not carry Tc-99m habits into PET.⁶⁷

Conclusion

Extremity dosimetry is where nuclear medicine radiation protection is won or lost, because the hands are where the dose is. The regulatory picture is unambiguous — a 500 mSv extremity limit and a 50 mSv monitoring trigger — but compliance on paper is not the same as protection in practice. The recurring lesson from the measurement literature is that dose across the hand is deeply non-uniform, that ring dosimeters at the finger base understate the fingertip peak, and that engineering controls and technique change the dose by an order of magnitude. A defensible extremity program issues the right dosimeter to the right people, interprets the reading with the fingertip in mind, drives dose down with shielding and automation, and trends the results so problems surface early. Done well, it keeps skilled staff safely below the limit while sustaining a high-throughput, high-energy radiopharmaceutical practice.

How DRPS Can Help

Diagnostic Radiation Physics Services helps nuclear medicine and PET facilities build practical, defensible extremity-dose programs: dosimeter selection and placement guidance, workplace dose-distribution studies, correction-factor determination, shielding and workflow reviews, investigational-level setting, and RSO program support prepared by board-certified medical physicists. This is delivered through our radiation safety officer, medical physicist consulting, and radiation safety training services.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A strong extremity-dose program is not about slowing the department down — it is about making the low-dose way of handling activity the fast, standard, everyday way.

Related Resources

• Occupational exposure monitoring
• Occupational eye lens dose
• NRC occupational dose limits under Part 20
• Nuclear medicine decontamination best practices
• Radioactive waste management in nuclear medicine
• Radiation Safety Officer consulting
• Radiation safety training

References

1. U.S. Nuclear Regulatory Commission. 10 CFR 20.1201: Occupational dose limits for adults. ecfr.gov
2. U.S. Nuclear Regulatory Commission. 10 CFR 20.1502: Conditions requiring individual monitoring of external and internal occupational dose. ecfr.gov
3. Sans Merce M, Ruiz N, Barth I, et al. Extremity exposure in nuclear medicine: preliminary results of a European study (ORAMED project). Radiation Protection Dosimetry. 2011;144(1-4):515-520. doi:10.1093/rpd/ncq574. doi.org
4. Salesses F, Perez P, Maillard AE, Blanchard J, Mallard S, Bordenave L. Effect of dosimeter's position on occupational radiation extremity dose measurement for nuclear medicine workers during 18F-FDG preparation for PET/CT. EJNMMI Physics. 2016;3(1):16. doi:10.1186/s40658-016-0152-5. doi.org
5. Guillet B, Quentin P, Waultier S, Bourrelly M, Pisano P, Mundler O. Technologist radiation exposure in routine clinical practice with 18F-FDG PET. Journal of Nuclear Medicine Technology. 2005;33(3):175-179. PubMed
6. Biran T, Weininger J, Malchi S, Marciano R, Chisin R. Measurements of occupational exposure for a technologist performing 18F FDG PET scans. Health Physics. 2004;87(5):539-544. doi:10.1097/01.hp.0000137180.85643.9d. doi.org
7. Blanc-Béguin F, Damien P, Floch R, et al. Radiation exposure to nuclear medicine technologists performing a V/Q PET: Comparison with conventional V/Q scintigraphy, [18F]FDG PET and [68Ga]Ga DOTATOC PET procedures. Frontiers in Medicine. 2022;9:1051249. doi:10.3389/fmed.2022.1051249. doi.org
8. International Commission on Radiological Protection. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP Publication 103. Annals of the ICRP. 2007;37(2-4). icrp.org
9. International Atomic Energy Agency. Radiation Protection and Safety of Radiation Sources: International Basic Safety Standards. IAEA Safety Standards Series No. GSR Part 3. Vienna: IAEA; 2014. iaea.org